Detalles de la búsqueda
1.
A prospective, multicenter, three-cohort study evaluating contrast-induced acute kidney injury (CI-AKI) in patients with cirrhosis.
J Hepatol;
80(1): 62-72, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37865273
2.
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD).
Dig Liver Dis;
2024 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38296690
3.
Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study.
Inflamm Bowel Dis;
29(1): 76-84, 2023 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35366312
4.
Successful use of Hemospray as a bridge to surgery in life-threatening bleeding from a gastrointestinal stromal tumor of the stomach.
Endoscopy;
48 Suppl 1: E232-3, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27367448
5.
Features of inflammatory bowel disease followed in a second level center in Northern Italy.
Minerva Med;
108(5): 481-482, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28728343
6.
Short duration treatment in genotype 1 chronic hepatitis C patients with rapid virologic response to pegylated interferon plus ribavirin.
Biomed Pharmacother;
65(4): 303-6, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21723079
7.
Bleeding ileal varices: a rare cause of chronic anemia in liver cirrhosis.
Intern Emerg Med;
6(3): 271-3, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20931298
8.
Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy: are they really cured?
Am J Gastroenterol;
101(8): 1811-6, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16780556
9.
A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy.
Hepatology;
36(4 Pt 1): 959-66, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12297844
10.
Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use.
Inflamm Bowel Dis;
14(8): 1168-70, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18357580
Resultados
1 -
10
de 10
1
Próxima >
>>